D Venzon

1.0k total citations
7 papers, 725 citations indexed

About

D Venzon is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, D Venzon has authored 7 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in D Venzon's work include Acute Lymphoblastic Leukemia research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (1 paper). D Venzon is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (1 paper). D Venzon collaborates with scholars based in United States and Malaysia. D Venzon's co-authors include Nita L. Seibel, Michael L. Nieder, Joseph E. Gootenberg, Carola Arndt, Ivan D. Horak, Aziza Shad, J E Neely, Ian Magrath, Magdalena Adde and Elaine S. Jaffe and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Applied Physiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D Venzon

7 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Venzon United States 7 325 321 153 149 149 7 725
EC Guinan United States 9 200 0.6× 144 0.4× 41 0.3× 166 1.1× 73 0.5× 14 734
Joerg Thomas Bittenbring Germany 13 301 0.9× 360 1.1× 103 0.7× 27 0.2× 67 0.4× 56 828
Sherwood P. Miller United States 13 311 1.0× 147 0.5× 87 0.6× 45 0.3× 184 1.2× 25 857
Esra Erden Türkiye 20 125 0.4× 112 0.3× 149 1.0× 30 0.2× 91 0.6× 90 1.3k
Wafae Iraqi France 8 139 0.4× 274 0.9× 242 1.6× 291 2.0× 47 0.3× 17 847
Ronald Rosenburg Germany 8 83 0.3× 178 0.6× 45 0.3× 46 0.3× 57 0.4× 11 1.2k
Itai Levi Israel 16 206 0.6× 212 0.7× 73 0.5× 15 0.1× 117 0.8× 60 844
Hassan El‐Solh Saudi Arabia 15 226 0.7× 164 0.5× 71 0.5× 14 0.1× 83 0.6× 40 693
Vinicio Fosser Italy 12 298 0.9× 69 0.2× 40 0.3× 89 0.6× 251 1.7× 27 559
Naoe Goto Japan 22 397 1.2× 470 1.5× 128 0.8× 11 0.1× 190 1.3× 66 1.2k

Countries citing papers authored by D Venzon

Since Specialization
Citations

This map shows the geographic impact of D Venzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Venzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Venzon more than expected).

Fields of papers citing papers by D Venzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Venzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Venzon. The network helps show where D Venzon may publish in the future.

Co-authorship network of co-authors of D Venzon

This figure shows the co-authorship network connecting the top 25 collaborators of D Venzon. A scholar is included among the top collaborators of D Venzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Venzon. D Venzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Adde, Melissa, Aziza Shad, D Venzon, et al.. (1998). Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.. PubMed. 25(2 Suppl 4). 33–9; discussion 45. 43 indexed citations
2.
Weintraub, Michael, Magdalena Adde, D Venzon, et al.. (1996). Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.. Journal of Clinical Oncology. 14(3). 935–940. 39 indexed citations
3.
Magrath, Ian, Magdalena Adde, Aziza Shad, et al.. (1996). Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.. Journal of Clinical Oncology. 14(3). 925–934. 317 indexed citations
4.
Wexler, Leonard H., Mary P. Andrich, D Venzon, et al.. (1996). Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.. Journal of Clinical Oncology. 14(2). 362–372. 171 indexed citations
5.
Alexander, H. Richard, et al.. (1992). Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats.. PubMed. 112(2). 188–93; discussion 193. 73 indexed citations
6.
Jensen, J C, Helen W. Pogrebniak, Harvey I. Pass, et al.. (1992). Role of tumor necrosis factor in oxygen toxicity. Journal of Applied Physiology. 72(5). 1902–1907. 72 indexed citations
7.
DeLaney, Thomas F., Jyh‐Chin Yang, M Lampert, et al.. (1990). Acute and long term effects on limb function of combined modality therapy in patients treated with limb sparing surgery for soft tissue sarcoma of the extremity. International Journal of Radiation Oncology*Biology*Physics. 19. 125–125. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026